Introduction
Discover how ImmunoIVD and Thermo Fisher Scientific are making an impact on newborn screening and clinical diagnostics by watching the video below.
See how ImmunoIVD develops effective assays used by laboratories to screen for severe combined immunodeficiency and spinal muscular atrophy. With these serious conditions, early diagnosis and treatment are pivotal to the life outcomes of the children.
About ImmunoIVD:
Sweden-based ImmunoIVD AB is dedicated to providing reliable, accessible and innovative assays for newborn screening for SCID, SMA and XLA. Our CE IVD marked SPOT-it™ Screening Kits have been used across Europe since 2018.
The assays are highly regarded for their reliability and easy-to-use workflow, requiring minimal laboratory space and equipment investment. We are recognized for our transparent communication and efficient support.